During the past decade, Texas Oncology - Round Rock Cancer Center conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 18 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Oncology - Round Rock Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "NSABP Foundation Inc" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 3 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Oncology - Round Rock Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Texas Oncology - Round Rock Cancer Center" are "Breast Cancer" (6 trials), "Breast Adenocarcinoma" (2 trials), "Clear Cell Renal Cell Carcinoma" (2 trials), "Stage IA Breast Cancer AJCC v7" (2 trials) and "Stage IB Breast Cancer" (2 trials). Many other conditions were trialed in "Texas Oncology - Round Rock Cancer Center" in a lesser frequency.

Most popular intervention types in "Texas Oncology - Round Rock Cancer Center" are "Drug" (23 trials), "Other" (13 trials), "Radiation" (11 trials), "Biological" (9 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Paclitaxel" (5 trials), "Quality-of-Life Assessment" (5 trials), "Bevacizumab" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Texas Oncology - Round Rock Cancer Center" are 17 trials for "All" genders, 11 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Texas Oncology - Round Rock Cancer Center". undefined are not yet recruiting, 1 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Texas Oncology - Round Rock Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Oncology - Round Rock Cancer Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".